Category: Biotech ETFs Soar on Gilead-Kite Deal

Biotech ETFs Soar on Gilead-Kite Deal

  1. Biotech ETFs Soar on Gilead-Kite Deal  Yahoo Finance
  2. Gilead Sciences’ (GILD) CEO John Milligan on Acquisition of Kite Pharma (Transcript)  Seeking Alpha
  3. ‘Game-changer’ cancer treatment is focus of Gilead’s $12 billion cell therapy deal  San Francisco Chronicle
  4. Full coverage

from Business – Google News https://finance.yahoo.com/news/biotech-etfs-soar-gilead-kite-164404090.html

Advertisements

Biotech ETFs Soar on Gilead-Kite Deal

  1. Biotech ETFs Soar on Gilead-Kite Deal  Yahoo Finance
  2. Gilead Sciences’ (GILD) CEO John Milligan on Acquisition of Kite Pharma (Transcript)  Seeking Alpha
  3. ‘Game-changer’ cancer treatment is focus of Gilead’s $12 billion cell therapy deal  San Francisco Chronicle
  4. Full coverage

from Business – Google News https://finance.yahoo.com/news/biotech-etfs-soar-gilead-kite-164404090.html